Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HCC70 | TNBC | Basal A | Cetuximab | EGFR | ErbB | 0.00000877 | uM | 7860.042 | 1.0594 | 1.1789 | 0.6736 | |
| HCC70 | TNBC | Basal A | Cetuximab | EGFR | ErbB | 0.00000877 | uM | 7857.042 | 0.9622 | 0.9364 | 1.1910 | |
| HCC70 | TNBC | Basal A | Cetuximab | EGFR | ErbB | 0.00000877 | uM | 9501.026 | 1.1286 | 1.3443 | 0.7616 | |
| HCC70 | TNBC | Basal A | Cetuximab | EGFR | ErbB | 0.0011 | uM | 7860.042 | 1.0453 | 1.1358 | 0.6736 | |
| HCC70 | TNBC | Basal A | Cetuximab | EGFR | ErbB | 0.0000438 | uM | 7860.042 | 1.0164 | 1.0489 | 0.6736 | |
| HCC70 | TNBC | Basal A | Cetuximab | EGFR | ErbB | 0.000219 | uM | 7860.042 | 1.0412 | 1.1235 | 0.6736 | |
| HCC70 | TNBC | Basal A | Cetuximab | EGFR | ErbB | 0.0274 | uM | 7860.042 | 0.9688 | 0.9079 | 0.6736 |